In vitro studies have identified ROS as intermediates in hypoxic stabilization of HIF-1α protein (Guzy et al., 2005), suggesting that elevated ROS levels and subsequent HIF-induced transcription may contribute to vasoconstriction and vascular remodeling in PPHN. The gene discussed is HIF1A; the disease is persistent fetal circulation syndrome.